Either you do not have the newest version of Adobe Flash®, or you have JavaScript disabled.

Please ensure you have these capabilities.


David A. Burns - Chairman of the Board of Managers & CEO
Mr. Burns has been for thirty-five years a practicing attorney. He was a partner first at the law firm of Baker Botts LLP and then at Dewey Ballantine LLP. As such he has represented financial institutions, oil and gas companies, energy companies, cable television and other business entities in financings, mergers and acquisitions, business start-ups, real estate transactions, work-outs and corporate reorganizations. Mr. Burns graduated from Harvard Law School in 1971 and is a fellow in the American College of Investment Counsel.

Hugh L. Hyde - CFO & Member of the Board of Managers
Mr. Hyde is a founding principal of Gulf Capital Partners, Inc. (GulfCap), a CPA and a retired partner of KPMG LLP. While at KPMG, Mr. Hyde was the regional practice director for banking and was involved heavily in SEC filings. Upon retirement from KPMG, Mr. Hyde became stockholder, director and President of a local bank in Houston and separately worked on a major financial institution restructure. During the past twelve years with GulfCap, in addition to providing services in corporate finance, mergers and acquisitions within several industries, he has served on several boards of directors, including portfolio companies managed by GulfCap, one of which is GeneExcel, Inc., a biotech company where he also serves as CFO.

H. Kirby Atwood, Jr. - President & Member of the Board of Managers
Mr. Atwood is a founding principal of GulfCap. Mr. Atwood received a BBA degree from the University of Texas in 1969 and, following active duty with the U.S. Navy, received his MBA. Prior to formation of GulfCap in 1995, he served as a Vice President of Commercial Lending in a major Houston bank, was a principal in one of the original cable television systems in Houston and was the owner of an independent E&P company. Mr. Atwood is the CEO and a director of GeneExcel, Inc., a biotech company included in the portfolio companies managed by GulfCap. He has specialized experience in corporate finance related to direct investment and mergers and acquisitions in biotech, telecommunications, electronics, manufacturing, banking and petroleum industries.

Michael J. Smith - COO & Member of the Board of Managers
Mr. Smith is a founding principal of GulfCap. He holds an aeronautical engineering degree from the University of Texas (1970) and an MBA from Southern Methodist University. He spent eight years as an engineer in the petroleum industry prior to becoming an investment banker on Wall Street, where he was involved in numerous of investment banking services, primarily to the petroleum industry. He returned to Texas in 1990 and has been involved in all forms of services provided by GulfCap to its clients and portfolio companies, including serving as a member of the board of managers and as CFO of Biocom, LLC, a designer and provider of highly technical operating systems which control biometric systems and large, sophisticated surveillance systems.

Jerry S. Trzeciak - Vice President, Sales & Marketing
Mr. Trzeciak brings 25 plus years of extensive expertise with companies like P&G and Sandoz in Customer Business Development within the pharmaceutical, biotechnology and life science industries. He has achieved success within multiple levels of Sales Management, Customer Business Development and Research. Mr. Trzeciak is currently consulting as VP of Business Development for GeneExcel, Inc., a biotech company addressing non-viral gene transportation and plasmid DNA purification.

Andres Zuluaga - Vice President Research & Development
Dr. Zuluaga has designed and developed optical instruments for over ten years. He previously headed a consulting firm, IO Consultants LLC, specializing in optical instrumentation. Dr. Zuluaga has been director of Systems and Development at InfraReDx where he led the research and design effort to develop an intravascular spectroscopy system to detect vulnerable plaques. He holds nine U.S. and multiple international patents. His Ph.D and M.S. degrees in electrical engineering were awarded by the University of Texas at Austin and his B.S. and B.A. degrees in engineering and economics were awarded by Swarthmore College.

David B. Jones - Vice President Regulatory Affairs and Quality
Mr. Jones has been in the medical industry for over twenty-five years, with over fifteen years in senior management, specializing in Regulatory Affairs and Quality Assurance. He also brings experience in direct patient care, medical research, operations and product development. As a former FDA investigator, Mr. Jones has intimate knowledge of FDA requirements and methods, and has successfully obtained numerous Class II and III approvals. In addition, he has consulted with a number of medical device and biotechnology companies in the US, Europe and Southeast Asia gaining many international product approvals. A graduate of Texas State University, Mr. Jones has also earned several quality and regulatory certifications.

Ronald G. Berlin - Senior Vice President of Manufacturing & Supply Chain
Mr. Berlin is an experienced Global Operations professional with a demonstrated history of developing high performance Teams that deliver outstanding results across multiple businesses. His most recent role was at In vivo, a Philips Medical Company, where, as Vice President of Global Operations, he was responsible for worldwide Manufacturing, Procurement, Quality, Materials, Service and Repair, and Logistics. Prior to that, Mr. Berlin was Vice President of Global Operations at Stryker Orthopedics where he was responsible for the Company's worldwide Manufacturing, Procurement, Distribution, Customer Service, and Logistics. Before joining Stryker Orthopedics, Mr. Berlin was Vice President of Global Supply Chain at Tenneco Automotive. Mr. Berlin joined Tenneco Automotive in 1996 as Director of Sales and Engineering, and later served as Business Unit Director.